IQV
IQVIA·NYSE
--
--(--)
--
--(--)
Signals Analysis
Bullish signal 4
Bearish signal 1
Consensus Rating "Strong Buy"
High Cash/net Profit Ratio
Revenue Beats Expectation
RSI Oversold
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About IQV
Iqvia Holdings Inc.
A global healthcare company that provides advanced analytics, technology solutions, and contract research services to the life sciences industry
Life Science Tools and Services
--
05/09/2013
New York Stock Exchange
88,000
12-31
Common stock
2400 Ellis Rd., Durham, North Carolina 27703
--
IQVIA Holdings Inc., is incorporated in Delaware. IQVIA is a leading global provider of clinical research services, business insights and healthcare intelligence to the life sciences and healthcare industries. The company is committed to accelerating the development and commercialization of Innovative Medical therapies to help improve patient outcomes and population health worldwide.
Company Financials
EPS
IQV has released its 2025 Q4 earnings. EPS was reported at 3.42, versus the expected 3.4, beating expectations. The chart below visualizes how IQV has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
IQV has released its 2025 Q4 earnings report, with revenue of 4.36B, reflecting a YoY change of 10.26%, and net profit of 514.00M, showing a YoY change of 17.62%. The Sankey diagram below clearly presents IQV's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
